• Company
• More companies are overcoming patents for Otezla
• by Kim, Jin-Gu Dec 28, 2022 05:48am

• Company
• Why no news is being heard on reimb extension for Bavencio
• by Dec 28, 2022 05:48am

• Company
• Phase 1/2 of CJ Bio's Microbiome has been applied
• by Dec 28, 2022 05:48am

• Company
• Kisqali Extends PFS by 1 yr in poor prognosis breast cancer
• by Dec 28, 2022 05:48am

• InterView
• Avodart, Real World Data
• by Dec 28, 2022 05:48am

• Policy
• Abbott’s Lipidil NT 145mg listed with reimbursement
• by Lee, Tak-Sun Dec 27, 2022 06:10am

• Company
• Samsung BioLogics did not receive 45.5 billion won
• by Dec 27, 2022 06:10am

• Product
• “Immediately stop enforcing the Healthcare Data Act”
• by Dec 27, 2022 06:10am

• Company
• LG Chem's Humira biosimilar applies for domestic permission
• by Dec 27, 2022 06:10am

• Policy
• Darzalex succeeded in renewing his contract with RSA
• by Kim, Jung-Ju Dec 26, 2022 06:07am